Showing results (271-280 of 4,869) with videos related to
Sort By:
Pageof 487
Urologic Oncology|February 19, 2021
Comparison between small renal masses 0-2 cm vs. 2.1-4 cm in size: A population-based studyAngela Pecoraro, Marina Deuker, Giuseppe Rosiello, et al.Urologic Oncology|March 9, 2021
Expression of programmed death ligand-1 (PD-L1) in metastatic and postchemotherapy viable testicular germ cell tumorsMofarej Al-Hogbani, Jérémie Duguay, Daniel-Christoph Wagner, et al.Urologic Oncology|March 9, 2021
4Kscore diagnostic value in patients with high-grade prostate cancer using cutoff values of 7.5% to 10%: A meta-analysisChao Mi, Lu Bai, Yuyang Yang, et al.Urologic Oncology|October 6, 2019
Efficacy and toxicity outcomes of elderly castrate-resistant prostate cancer patients treated with docetaxel-A pooled analysis of 3 randomized studiesOmar Abdel-RahmanUrologic Oncology|December 28, 2021
Oncological outcomes of surgery for isolated retroperitoneal recurrence in renal cancer patients after radical nephrectomyMichal Staník, Alexander Poprach, Simona Littnerová, et al.Urologic Oncology|October 22, 2022
UnCHAARTED territory: The role of docetaxel rechallenge following chemohormonal therapy for metastatic castration-sensitive prostate cancerMary Mahler, Esmail Al-Ezzi, Noa Shani Shrem, et al.Urologic Oncology|October 25, 2022
What is the most effective way to ensure that patients successfully undergo germline testing for prostate cancer?David Ahlborn, Ilene Staff, Tara McLaughlin, et al.Urologic Oncology|July 12, 2015
Novel and next-generation androgen receptor-directed therapies for prostate cancer: Beyond abiraterone and enzalutamideRichard M Bambury, Dana E RathkopfUrologic Oncology|July 13, 2015
The YAP1 oncogene contributes to bladder cancer cell proliferation and migration by regulating the H19 long noncoding RNAShi Li, Zhe Yu, San-San Chen, et al.Urologic Oncology|July 13, 2015
Validation of a frailty index in patients undergoing curative surgery for urologic malignancy and comparison with other risk stratification toolsDanny Lascano, Jamie S Pak, Max Kates, et al.Pageof 487